Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000211709 | SCV004468764 | uncertain significance | Hereditary spastic paraplegia 62 | 2023-02-18 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Arg255*) in the ERLIN1 gene. It is expected to result in an absent or disrupted protein product. However, the current clinical and genetic evidence is not sufficient to establish whether loss-of-function variants in ERLIN1 cause disease. This variant is present in population databases (no rsID available, gnomAD 0.007%). This premature translational stop signal has been observed in individuals with hereditary spastic paraplegia (PMID: 24482476; Invitae). ClinVar contains an entry for this variant (Variation ID: 226426). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
OMIM | RCV000211709 | SCV000268706 | pathogenic | Hereditary spastic paraplegia 62 | 2014-01-31 | no assertion criteria provided | literature only |